Benign Eyelid Lesions: Types and Treatment Options

What are benign eyelid lesions?

A benign eyelid lesion is any non-cancerous growth or change in the tissue of the eyelid. Because eye skin is the thinnest on the body and absorbs decades of ultraviolet sun exposure, the lids develop a wide range of bumps, cysts, and pigmented spots over a lifetime. Most are not vision-threatening, though they can irritate the eye, block part of the visual field, or simply bother a patient for cosmetic reasons. The lids contain skin, muscle, fat, tarsus, and several glands, including the meibomian glands, the sebaceous glands of Zeis, and the sweat glands of Moll, and a benign lesion can arise from any of these structures.

The most common types of benign eyelid lesions

There are many types of benign eyelid lesions, but a handful account for most of what walks through the door. A chalazion is the most common benign eyelid lesion, a firm and usually painless lipogranuloma that forms when a meibomian gland becomes blocked, and its contents leak into the surrounding tarsal tissue. A hordeolum, or stye, is an acute, tender, often red bump near the lash line caused by a bacterial infection of an eye gland, and unlike a chalazion, it is typically painful. Squamous papillomas, commonly called skin tags, are the most common benign eyelid lesions of epithelial origin. These flesh-colored growths may sit on a broad base or a narrow stalk and are common in middle-aged and older patients.

Seborrheic keratosis is another frequent finding, a waxy, stuck-on, often pigmented plaque that becomes more common in patients over the age of 50. It is benign, though a sudden crop of new ones is worth noting. Verruca vulgaris is a viral wart caused by human papillomavirus, and on the lid margin, it can shed virus onto the ocular surface and cause irritation. Molluscum contagiosum, caused by a poxvirus, presents as small dome-shaped papules with a central dimple and is most common in children and immunocompromised patients. Xanthelasmas are soft, yellow cholesterol deposits on the inner eye skin that can be associated with elevated lipids. An epidermal inclusion cyst is a slowly enlarging, keratin-filled cyst under the skin, while a hidrocystoma is a clear, fluid-filled sweat-gland cyst near the lid margin that may swell in hot weather. A nevus is a pigmented mole that is usually stable and benign, though any change in size, shape, or color should be evaluated. Finally, a pyogenic granuloma is a rapidly growing red vascular nodule that bleeds easily, often after minor trauma or surgery.

Which benign eyelid lesions can be treated with chemical cautery?

Chemical cautery is well suited to small, superficial, benign lesions that sit on or just above the skin surface. Good candidates include squamous papillomas and other skin tags, small verruca vulgaris lesions (warts), xanthelasma, and seborrheic keratoses. Because the technique treats tissue precisely and without a blade, it fits the quick, in-office removals optometrists are increasingly performing. Deeper cysts, anything fixed to underlying tissue, and any lesion with malignant features fall outside that scope and should be excised or referred.

How are benign eyelid lesions treated?

Not every benign eyelid lesion needs to be removed. When a growth is clearly benign and is not affecting vision, comfort, or appearance, monitoring is reasonable. When treatment is warranted, the common options are excision, curettage, cryotherapy, electrocautery, chemical cautery, and laser. The right choice depends on the lesion type, its depth, and its location relative to the lid margin and lashes. Superficial benign lesions are often handled in a single short visit, while lesions that are deep, recurrent, or uncertain are better sent for excisional biopsy so the tissue can be examined.

Benign vs. malignant: when to biopsy or refer

Benign eyelid lesions outnumber malignant ones by roughly six to eight to one, but the two can look alike, and a small share of lesions judged benign on sight turn out to be malignant under the microscope. Take a short history covering onset, growth rate, bleeding, prior skin cancer, and sun exposure, then examine the lesion at the slit lamp. The classic red flags are the ABCDEs: asymmetry, irregular borders, color variation, a diameter over 6 mm, and evolution or change over time. Loss of eyelashes, ulceration that will not heal, a pearly nodule, or a lesion fixed to deeper tissue all raise suspicion. Precancerous lesions such as actinic keratosis and keratoacanthoma, and malignant ones such as basal cell carcinoma, the most common eye cancer, along with squamous cell carcinoma, sebaceous carcinoma, and melanoma, need biopsy and appropriate management rather than simple in-office removal. When in doubt, send tissue to pathology.

Treating benign eyelid lesions in your practice

Managing benign eyelid lesions is becoming a routine part of modern optometric care and can create a valuable new in-office revenue stream. Rather than referring every patient elsewhere, eligible practices can provide treatment themselves, improving the patient experience while keeping both the procedure and associated revenue within the practice.

Many optometric practices are already incorporating in-office lesion removal into their services. At least 33 states now allow optometrists to perform minor surgical procedures, and even in states where removal is referred, every OD should be able to confidently identify benign periocular lesions and counsel patients on their treatment options.

For eligible procedures, treatment is often covered by insurance when medical necessity and payer requirements are met, making it an accessible option for many patients while creating an additional reimbursable service for the practice.

The Derma Cautery training and treatment package was built to support licensed optometrists who want to add this service. It provides a standardized treatment protocol, the necessary materials, and coding guidance to help practices confidently treat appropriate benign periocular lesions in the office. If you are ready to add in-office lesion removal to your practice, explore what the complete Derma Cautery package includes.

FAQ (for optometrists)

Which benign eyelid lesions can optometrists treat in-office?

Small, superficial benign lesions are the best candidates, including squamous papillomas (skin tags), verrucae, xanthelasma, seborrheic keratoses, and minor surface growths. Deeper cysts, anything fixed to underlying tissue, and any lesion with suspicious features should be excised or referred rather than treated in the chair.

Are optometrists allowed to remove eyelid lesions?

It depends on the state. A growing number of states grant optometrists minor surgical or in-office procedure privileges, starting with Oklahoma in 1998. Scope varies, so confirm your state board’s rules and work within the procedures you are trained and credentialed to perform.

How do you differentiate a benign eyelid lesion from a malignant one before treating?

Take a focused history (onset, growth rate, bleeding, prior skin cancer, sun exposure) and examine the lesion at the slit lamp. Red flags include rapid growth, ulceration, madarosis, irregular borders, color variation, and a firm pearly nodule. When malignancy cannot be ruled out clinically, biopsy or refer rather than remove.

Should benign eyelid lesions be sent to pathology after removal?

Submitting excised tissue is good practice. Because a small share of lesions that look benign clinically prove malignant histologically, many clinicians send all excised masses for confirmation. It protects the patient and documents medical necessity in the record.

How does chemical cautery compare to cryotherapy or excision for these lesions?

Chemical cautery treats superficial benign lesions precisely and without a blade, which suits quick in-office removals near the eye. Cryotherapy can be less precise on small lid lesions, and excision is better for deeper or uncertain growths that need tissue for pathology. Match the method to the lesion.

What does an optometrist need to start offering in-office lesion removal?

Within your state’s scope, you need appropriate training, a defined protocol, the right materials, and coding guidance to bill correctly. A structured system like the Derma Cautery training and treatment package bundles the protocol, kit, and support so a practice can add the service confidently.